ANAB•benzinga•
AnaptysBio To Reveal Updated Data From Phase 2b Trial of Rosnilimab, A PD-1 Depleter And Agonist, For Rheumatoid Arthritis On June 3, 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 27, 2025 by benzinga